Prosecution Insights
Last updated: August 18, 2026
Application No. 18/794,905

SEALING MEMBER AND BLOOD BAG SET

Non-Final OA §102
Filed
Aug 05, 2024
Priority
Mar 07, 2022 — JP 2022-034092 +1 more
Examiner
ZIMBOUSKI, ARIANA
Art Unit
Tech Center
Assignee
Terumo Corporation
OA Round
1 (Non-Final)
68%
Grant Probability
Favorable
1-2
OA Rounds
1y 3m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 68% — above average
68%
Career Allowance Rate
414 granted / 608 resolved
+8.1% vs TC avg
Strong +32% interview lift
Without
With
+31.6%
Interview Lift
resolved cases with interview
Typical timeline
3y 4m
Avg Prosecution
17 currently pending
Career history
629
Total Applications
across all art units

Statute-Specific Performance

§101
3.7%
-36.3% vs TC avg
§103
45.6%
+5.6% vs TC avg
§102
12.9%
-27.1% vs TC avg
§112
31.3%
-8.7% vs TC avg
Black line = Tech Center average estimate • Based on career data from 608 resolved cases

Office Action

§102
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claim(s) 8 -20 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Kawasumi Chemical Industry Co., LTD. (JP H04-27936), hereinafter Kawasumi, supplied in the August 6, 2024 filed IDS. Regarding claim 8, Kawasumi discloses a sealing member 2, 3 for a medical tube 8, the sealing member comprising: a base 3 extending along an axis of the sealing member from a proximal end of the base to a distal end of the base (see Figs. 1-4), wherein the base comprises a base flow path lumen 7 extending from the proximal end of the base to the distal end of the base (see Fig. 1); a plug 2 interconnected to the base at the distal end of the base (see Fig. 1), wherein the plug completely covers and blocks the base flow path lumen at the distal end of the base (see Fig. 1); and a joint 4 disposed between the base and the plug (see Fig. 1), the joint comprising at least one stress concentration groove extending into the sealing member in a direction toward the axis of the sealing member (see Fig. 1), the at least one stress concentration groove extending around a periphery of the joint (see Fig. 1); wherein the plug comprises a noncircular cross-sectional shape (see Figs. 2-3(c), wings part 6 and fluid channel 15 in valleys creates a non-circular shape), the noncircular cross-sectional shape surrounding the axis of the sealing member (see Figs. 2-3(c), and wherein the noncircular cross-sectional shape undulates between concave and convex portions following an outer peripheral surface of the plug (see Figs. 2-3(c), winds 6 and fluid channels in valleys create alternating concave and convex portions). Regarding claim 9, Kawasumi discloses the noncircular cross-sectional shape undulates longitudinally as well as circumferentially as the noncircular cross-sectional shape follows the outer peripheral surface of the plug see Figs. 1-2, the noncircular cross-sectional shape follows along on a longitudinal distance of the plug). Regarding claim 10, Kawasumi discloses the sealing member is movable between a closed state (see Figs. 1-2) and a fluid communication state (see Fig. 4), wherein in the closed state the at least one stress concentration groove is entirely unbroken along the periphery of the joint (see Fig. 1), and wherein in the fluid communication state the at least one stress concentration groove is broken along at least a portion of the periphery of the joint (see Fig. 4). Regarding claim 11, Kawasumi discloses the noncircular cross-sectional shape of the plug comprises at least two recessed face portions 15 and at least two ridges 6 (see Figs. 3(a)-3(c)), wherein a first recessed face portion of the at least two recessed face portions is disposed between adjacent ridges of the at least two ridges (see Figs. 3(a)-3(c)). Regarding claim 12, Kawasumi discloses the at least two ridges comprise convex surfaces of the outer peripheral surface of the plug, wherein the at least two recessed face portions comprise concave surfaces of the outer peripheral surface of the plug (see Figs. 3(a)-3(c)). Regarding claim 13, Kawasumi discloses a first radial distance from the axis to the outer peripheral surface of the plug at each of the at least two ridges is greater than a second radial distance from the axis to the outer peripheral surface of the plug at each of the at least two recessed face portions (see Figs. 2-3(c)). Regarding claim 14, Kawasumi discloses a circle inscribed within the noncircular cross-sectional shape contacts a portion of the joint adjacent each of the at least two recessed face portions (see Fig. 2), and wherein a radially extending space is disposed between the circle inscribed within the noncircular cross-sectional shape and a portion of the joint adjacent each of the at least two ridges the joint (see Fig. 2). Regarding claim 15, Kawasumi discloses the at least one stress concentration groove extending around the periphery of the joint comprises a thinnest section of material of the sealing member (see Fig. 1). Regarding claim 16, Kawasumi discloses the base comprises an outer circumferential face arranged adjacent the proximal end of the base, and wherein the outer circumferential face is sized to seal against an inner face of a medical tube in a liquid-tight contact arrangement (see Figs. 1, 4). Regarding claim 17, Kawasumi discloses wherein, in the closed state, the sealing member prevents fluid flow past the sealing member through the medical tube (see Fig. 1), and wherein, in the fluid communication state, the sealing member allows fluid flow past the sealing member through the medical tube via the base flow path lumen (see Fig. 4). Regarding claim 18, Kawasumi discloses the distal end of the base tapers from a first outer circumferential face diameter to a second outer circumferential face diameter, wherein the first outer circumferential face diameter is greater than the second outer circumferential face diameter (see Figs. 1, 4). Regarding claim 19, Kawasumi discloses the noncircular cross-sectional shape of the plug comprises three recessed face portions and three ridges, wherein a first recessed face portion of the three recessed face portions is disposed between a first set of two adjacent ridges of the three ridges, wherein a second recessed face portion of the three recessed face portions is disposed between a second set of two adjacent ridges of the three ridges, and wherein a third recessed face portion of the three recessed face portions is disposed between a third set of two adjacent ridges of the three ridges (see Fig. 3(b)). Regarding claim 20, Kawasumi discloses each ridge of the three ridges is separated from one another by 120 degrees (see Fig. 3(b)). Allowable Subject Matter Claims 1-7 are allowable. The following is a statement of reasons for the indication of allowable subject matter: the closest prior art found is Kawasumi, which does not disclose the required breakable portion being a non-circular shape as claimed. In applicant’s claimed invention, the breakable portion “is non-circular in shape, the breakable portion including a plurality of tops and a plurality of connections between the plurality of tops” and a separate part from the plug that is connected to the base through the neck, and such a shape of the breakable portion not only helps in breaking the breakable portion smoothly, but also helps prevent/reduce the risk of hemolysis because the breakable portion is large in flow-path cross-sectional area (see paragraphs 9, 44, and 46 of the Specification filed August 5, 2024). Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. Hall et al. (US 2018/0099135), disclosing a medical fluid line connector with a plug and base connected via a joint, the plug having a non-circular cross section; Nisipeanu et al. (US 2015/0238746), disclosing a medical fluid line connector with a plug and base connected via a joint, the plug having a non-circular cross section. Any inquiry concerning this communication or earlier communications from the examiner should be directed to ARIANA ZIMBOUSKI whose telephone number is (303)297-4665. The examiner can normally be reached 8:30 - 5:00 PST M-F. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, REBECCA E EISENBERG can be reached at (571) 270-5879. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /ARIANA ZIMBOUSKI/Primary Examiner, Art Unit 3781
Read full office action

Prosecution Timeline

Aug 05, 2024
Application Filed
Aug 06, 2026
Non-Final Rejection mailed — §102 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12702621
PHARMACEUTICAL CONTAINERS INCLUDING HIGH CTE SEALING ASSEMBLY ENCIRCLING OUTER SURFACE OF CONTAINER
3y 9m to grant Granted Aug 11, 2026
Patent 12702815
EXTRACORPOREAL CIRCULATION CIRCUIT
3y 0m to grant Granted Aug 11, 2026
Patent 12691037
MEDICINAL FLUID DELIVERY DEVICE
2y 10m to grant Granted Jul 28, 2026
Patent 12685655
DEVICES, SYSTEMS, AND METHODS FOR OCCLUDING AN ANATOMICAL PASSAGE
3y 5m to grant Granted Jul 21, 2026
Patent 12686603
Dispenser Actuator Assembly
3y 6m to grant Granted Jul 21, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
68%
Grant Probability
99%
With Interview (+31.6%)
3y 4m (~1y 3m remaining)
Median Time to Grant
Low
PTA Risk
Based on 608 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month